PROTEINURIA
Clinical trials for PROTEINURIA explained in plain language.
Never miss a new study
Get alerted when new PROTEINURIA trials appear
Sign up with your email to follow new studies for PROTEINURIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for cancer patients: Kidney-Sparing drug trial begins
Disease control Not yet recruitingThis early-stage study tests if sparsentan can reduce high levels of protein in the urine, a sign of kidney damage, in 20 cancer patients taking certain targeted therapies. The goal is to see if the drug can help protect kidney function without stopping cancer treatment. Particip…
Matched conditions: PROTEINURIA
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Can a herbal granule ease a common side effect of breast cancer treatment?
Symptom relief Not yet recruitingThis study tests whether adding Huaier Granule to standard care can better treat proteinuria (excess protein in urine) in breast cancer patients who developed this side effect from immunotherapy or anti-angiogenic therapy. About 120 women aged 18-75 will be randomly assigned to r…
Matched conditions: PROTEINURIA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Symptom relief
Last updated May 26, 2026 05:49 UTC
-
Herbal granules aim to ease kidney side effect of lung cancer drugs
Symptom relief Not yet recruitingThis study tests whether Huaier Granules, a traditional Chinese medicine, can reduce protein in the urine (proteinuria) caused by two lung cancer drugs, Bevacizumab and Anlotinib. About 40 adult lung cancer patients with mild to moderate proteinuria will take the granules for 16 …
Matched conditions: PROTEINURIA
Phase: PHASE4 • Sponsor: Fudan University • Aim: Symptom relief
Last updated May 19, 2026 11:48 UTC
-
Computer alert aims to catch kidney disease earlier
Knowledge-focused Not yet recruitingThis study tests whether an alert in the electronic health record can help primary care doctors refer patients with blood and protein in their urine to kidney specialists. About 1,200 adults at Geisinger Clinic will take part. The goal is to see if the alert improves referral rat…
Matched conditions: PROTEINURIA
Phase: NA • Sponsor: Geisinger Clinic • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC
-
New study will examine how C3G patients fare on iptacopan in everyday practice
Knowledge-focused Not yet recruitingThis study will review medical records of about 83 adults with C3 glomerulopathy (a rare kidney disease) who are taking the drug iptacopan. Researchers want to describe the patients' health history, lab results, and how their disease changes over 12 months of treatment. The goal …
Matched conditions: PROTEINURIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 18, 2026 12:02 UTC